Pelthos Therapeutics Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | +26.8% | +16.2% | +43.1% | – | |
| – | – | – | – | – | – | – | – | -11.8% | +21.0% | -7.2% | – | |
| – | – | – | – | – | – | – | – | +105.6% | +11.9% | +90.8% | – | |
| – | -79.7% | -97.2% | +3,100.6% | -31.2% | -31.9% | +165.0% | -71.8% | +157.9% | -50.3% | +222.6% | – | |
| – | – | +19.3% | -6.7% | -5.7% | +6.5% | +65.6% | +343.2% | +7.1% | +2.9% | +39.2% | – | |
| – | -50.1% | -8.8% | +16.1% | -10.9% | +0.5% | +76.1% | +450.8% | -4.4% | +9.9% | +49.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +291.9% | -98.2% | +252.8% | +176.7% | +23.8% | +63.5% | +516.0% | -2.4% | +79.1% | +1.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.